342 Pill - pink round, 10mm
Pill with imprint 342 is Pink, Round and has been identified as Carbamazepine (chewable) 100 mg. It is supplied by Caraco Pharmaceutical Laboratories.
Carbamazepine is used in the treatment of Trigeminal Neuralgia; Bipolar Disorder; Schizoaffective Disorder; Epilepsy; Seizures and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 342
Carbamazepine (chewable)
- Imprint
- 342
- Strength
- 100 mg
- Color
- Pink
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Caraco Pharmaceutical Laboratories
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 57664-0342 (Discontinued) | Caraco Pharmaceutical Laboratories, Ltd. |
| 00904-3854 | Major Pharmaceuticals |
| 13668-0271 | Torrent Pharmaceuticals Limited |
Related images for "342"
More about carbamazepine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (342)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: dibenzazepine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Carbamazepine drug information
- Carbamazepine (Intravenous) (Advanced Reading)
- Carbamazepine (Oral) (Advanced Reading)
- Carbamazepine Chewable Tablets
- Carbamazepine Extended-Release Capsules (Carbatrol)
Other brands
Tegretol, Carbatrol, Tegretol XR, Equetro, ... +2 more
Professional resources
- Carbamazepine monograph
- Carbamazepine (FDA)
- Carbamazepine Capsules (FDA)
- Carbamazepine Chewable (FDA)
- Carbamazepine ER (FDA)
- Carbamazepine Oral Suspension (FDA)
Other brands
Tegretol, Carbatrol, Equetro, Epitol, Carnexiv
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
